COVID-19 EMERGENCY RESEARCH FUND
Technion is at the forefront of science and technology worldwide, and during this time of crisis, is collaborating closely with the health system and hospitals in search of immediate solutions to the challenges they are facing.
Technion researchers are working round the clock in more than 45 Technion labs, developing new innovations, promising tests, and possible cures for Covid-19
HELP TECHNION REALIZE THE PROMISE
Whenever the world is facing a problem, no matter how challenging, the Technion is there, using its expertise to improve and save lives. Your support will help Technion researchers realize the promise of life-saving innovation by providing urgently needed funds for COVID-19 research.
Prof. Avi Schroeder is developing a COVID-19 vaccine based on immunity-boosting research for a virus found in farmed shrimp. Viruses require certain proteins to replicate and Prof. Shroeder believes we can use stop their production effectively stopping the virus. Invented at Technion and being commercialized by Technion start-up ViAqua Therapeutics.
Severe COVID-19 cases patients can now be treated in a non-invasive manner. This new (NIV) hood, the Greenhouse™, is the first of its kind - eliminating intubation and heavy sedation while protecting medical staff. Currently being used in select hospitals in Israel, this technology was developed by Tamar Robotics, co-founded by Technion Alumni.
Researchers at the Technion and Rambam Health Care Campus have developed a method called pooling for testing over 60 infected patients simultaneously. Speeding up the process means faster detection of infected patients.
Technion faculty, alumni and volunteers joined forces with students from the FIRST Robotics Group. Together they have built a robot helping medical staff at Rambam Health Care Campus in Haifa to safely care for Covid-19 patients.
Rethinking the future of medicine, Technion alumni are applying their AI-based remote screening platform to monitor the spread of the COVID-19. Currently being used by Israel and set to launch globally.
Meet “Maya”, the nanotech solution protecting healthcare workers from exposure to the nanosized virus droplets. The protective sticker, 3D printed at Technion, releases antiseptic on contact with the virus.